ACG 2019 Annual Scientific Meeting

Breakfast A: IBD at the Extremes: From Babies to Boomers

Moderator: Christina Y. Ha, MD, FACG

• Preconception to Pregnancy
  Eugenia Shmidt, MD
  Emphasize the importance of pre-, peri-, and postpartum care for women with IBD.
• Transitions of Care
  Jill K. J. Gaidos, MD, FACG
  Propose strategies for seamless transition from pediatric to adult GI care.
• The Older Patient
  Christina Y. Ha, MD, FACG
  Distinguish the additional needs of older patients living with IBD.

Breakfast B: Anorectal Disorders

Moderator: Lawrence J. Brandt, MD, MACG

• I Am Itching to Show and Tell: Benign and Malignant Anorectal Lesions
  Lawrence J. Brandt, MD, MACG
  Recognize various benign and malignant anorectal pathologies.
• Taking on Hemorrhoids: Things to Consider
  Harry E. Sarles, Jr., MD, FACG
  Identify and describe various options available to treat hemorrhoidal disease.
• Management of Anorectal POOpouri: Pruritus, Proctalgia, Seepage, and Perianal Dermatitis
  Satish S.C. Rao, MD, PhD, FACG
  Describe various treatment options for common perianal symptoms.

Breakfast C: Challenges in ERCP

Moderator: Prabhleen Chahal, MD, FACG

• Evaluation and Management of Hilar Obstruction
  Prabhleen Chahal, MD, FACG
  Outline new paradigms in the management of hilar biliary obstruction.
• Diverticular Bleeding: Can We Prevent It, How Best to Treat It, and Can We Decrease Its Recurrence?
  Vivek Kaul, MD, FACG
  Explain how to approach and manage difficult ERCP scenarios. (Note to Faculty: cover difficult biliary cannulation, altered anatomy, large CBD stone, etc.)
• Quality Indicators in ERCP
  Patrick S. Yachimski, MD, MPH
  Identify best practice principles and quality indicators in ERCP practice.

Breakfast D: Conundrums in Motility: How the Experts Handle Tough Cases

Moderator: John E. Pandolfino, MD, MSCI, FACG

• UES Dysfunction/Cricopharyngeal Bar
  Reza Shaker, MD, FACG
  Describe the management of upper esophageal sphincter dysfunction/cricopharyngeal bar through the evaluation of cases.
• Ineffective Esophageal Motility/Hypomotility Disorders
  C. Prakash Gyawali, MD, MRCP, FACG
  Discuss the management of IEM/hypomotility disorders through the evaluation of cases.
• GEJ Outflow Obstruction
  John E. Pandolfino, MD, MSCI, FACG
  Explain the management of gastroesophageal junction outflow obstruction through the evaluation of cases.

Breakfast E: Remaining Challenges in the Management of Hepatitis C Infection
Moderator: Norah A. Terrault, MD, MPH, FACG

• Hepatitis C Management: Overview and Update
  Nancy S. Reau, MD, FACG
  Review the current state-of-the-art treatment options for hepatitis C.
• Difficult-to-Treat HCV Patients
  Norah A. Terrault, MD, MPH, FACG
  Discuss the treatment options for hepatitis C in patients with decompensated cirrhosis, recognize treatment options for HCV patients who have failed prior therapies, and identify the unique needs of injection drug users with HCV infection.
• Management of the Cured HCV Patient
  Joseph K. Lim, MD, FACG
  Identify the long-term management of the hepatitis C patient who has been cured of their infection.

Breakfast F: Challenges in Small Bowel Bleeding
Moderator: Elizabeth Rajan, MD

• Approach to the Patient with Obscure GI Bleeding
  Elizabeth Rajan, MD
  Describe the classification and etiologies of small bowel bleeding and explain the approach to initial work-up of patients with small bowel bleeding.
• Update and Quality Metrics in Capsule Endoscopy
  Jodie A. Barkin, MD
  Discuss new updates in video capsule endoscopy technology, and define markers of quality in the preparation, performance, and interpretation of video capsule endoscopy with strategies for optimization.
• Medical and Endoscopic Management of Small Bowel Angioectasias and Other Lesions
  Kathy P. Bull-Henry, MD, FACG
  Recognize the role of small bowel enteroscopy and medical therapies in managing small bowel bleeding due to angioectasias and other lesions.

Symposium 1A: CRC Screening and Surveillance Conundrums

Moderator: Aasma Shaukat, MD, MPH, FACG

• At What Age Should I Start Screening and When Should I stop?
  Aasma Shaukat, MD, MPH, FACG
  Discuss the evidence to support or refute starting colonoscopy screening at age 45 and stopping after age 75.
• Colon Polypectomy, What Should You Use: Forceps to ESD
  Mark B. Pochapin, MD, FACG
  Review best practice for colon polyp removal depending on polyp size.
• What Should I Do With a Positive Stool Test After a Negative Colonoscopy?
  Carol A. Burke, MD, FACG
  Explain an evidence-based approach to a positive stool test after a recent negative colonoscopy.

Symposium 1B: Controversies in Esophageal Disease: Expert Debates

Moderator: Christine Y. Hachem, MD, FACG

• Do Endoscopic Anti-Reflux Therapies Have a Role in 2019?
  Pro: Ronnie Fass, MD, FACG
  Con: Seth J. Richter, MD, FACG
  Compare effectiveness of endoscopic anti-reflux therapies in the management of GERD.
• Debating the Management of Achalasia: Is E-POEM Now a First-Line Therapy?
  Pro: Marcelo F. Vela, MD, MSCR, FACG
  Con: Philip O. Katz, MD, MACG
  Compare effectiveness of POEM, pneumatic dilation, and Heller myotomy in the management of achalasia.

Symposium 1C: Improving Your Clinical Practice

Moderator: Shivangi T. Kothari, MD, FACG

• Quality Metrics in Your Endoscopic Practice
  Colleen M. Schmitt, MD, MHS, FACG
  Define quality metrics in the endoscopy unit and gastroenterology clinic and recognize the role of GIQuIC and tools for quality reporting.
• Integrating Advanced Practice Providers in Your Clinical Practice
  Shivangi T. Kothari, MD, FACG, AND Mary S. Vetter, ANP
  Explain how APPs can play an important role in your gastroenterology practice and identify techniques for their training.
• Telemedicine in Gastroenterology: Why and How to Adopt It Into Your Practice
  Harry E. Sarles, Jr., MD, FACG
  Describe how telemedicine adds value to the practice of gastroenterology, how to integrate telemedicine into your practice, and discuss liability issues relative to telehealth.

• Plenary Session 1A
• Plenary Session 1B

Symposium 2A: Positioning Therapies in IBD: What’s the Initial Treatment Strategy?

Moderator: David T. Rubin, MD, FACG

• Low-Risk Crohn’s Disease – Do We Need to Do Anything at All?
  Kim L. Isaacs, MD, PhD, FACG
  Define and identify treatment strategies for low-risk Crohn’s disease.
• High-Risk Ulcerative Colitis – Where Do We Start?
  David T. Rubin, MD, FACG
  Discuss medication selection based on patient and disease-related factors for high-risk UC.
• High-Risk Crohn’s Disease – More Options, More Questions?
  Uma Mahadevan, MD, FACG
  Position the newer mechanisms of action into the treatment algorithm for high-risk Crohn’s disease patients.

Symposium 2B: Challenging Functional Complaints

Moderator: Linda Anh B. Nguyen, MD

• POTS and EDS: What Does a Gastroenterologist Need to Know?
  Linda Anh B. Nguyen, MD
  Recognize and discuss the emerging overlap between postural tachycardia syndrome and Ehlers-Danlos syndromes in gastrointestinal disorders.
• Neuromodulation for Functional Abdominal Pain
  Brooks D. Cash, MD, FACG
  Discuss the diagnosis and treatment of chronic functional abdominal pain.
• Things That Make You Go Green: Cyclic Vomiting, Cannabinoid Hyperemesis, and Chronic Nausea
  Edith Y. Ho, MD, MS, FACG
  Differentiate between different functional etiologies of nausea and vomiting.

Symposium 2C: Live From San Antonio! The 7th Annual Endoscopy Video Forum

Moderators: Seth A. Gross, MD, FACG, and Vivek Kaul, MD, FACG

Judges: Jodie A. Barkin, MD; Qiang Cai, MD, PhD, FACG; Prabhleen Chahal, MD, FACG; David A. Greenwald, MD, FACG; Vanessa M. Shami, MD, FACG; Allison R. Schulman, MD, MPH; and Kevin E. Woods, MD, MPH
Demonstrate interesting endoscopic findings and techniques encountered in daily clinical practice.